Akebia Therapeutics
AKBA
AKBA
133 hedge funds and large institutions have $218M invested in Akebia Therapeutics in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 20 closing their positions.
Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
28
Increased
43
Reduced
35
Closed
20
Calls
$5.2M
Puts
$674K
Net Calls
+$4.53M
Net Calls Change
+$4.81M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$4.35M |
| 2 |
2
Goldman Sachs
New York
|
$4.85M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$29.9M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$5.86M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$1.28M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MFG
151
Magnus Financial Group
New York
| – | – | – | – |
|
|
FWM
152
Focused Wealth Management
Newburgh,
New York
| $0 | 65 | – | – |
|
|
CFGS
153
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
154
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $0 | 10 | – | – |
|
|
HCP
155
Hexagon Capital Partners
Rogers,
Arkansas
| $0 | 186 | – | – |
|